Kilitch Drugs (India) Limited

BSE:524500 Stock Report

Market Cap: ₹5.2b

Kilitch Drugs (India) Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Mukund Mehta

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure32.7yrs
CEO ownership7.1%
Management average tenure2.7yrs
Board average tenure7.3yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Mukund Mehta's remuneration changed compared to Kilitch Drugs (India)'s earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

₹165m

Jun 30 2024n/an/a

₹126m

Mar 31 2024n/an/a

₹146m

Dec 31 2023n/an/a

₹146m

Sep 30 2023n/an/a

₹140m

Jun 30 2023n/an/a

₹117m

Mar 31 2023₹6m₹6m

₹104m

Dec 31 2022n/an/a

₹98m

Sep 30 2022n/an/a

₹85m

Jun 30 2022n/an/a

₹83m

Mar 31 2022₹6m₹6m

₹74m

Dec 31 2021n/an/a

₹52m

Sep 30 2021n/an/a

₹63m

Jun 30 2021n/an/a

₹62m

Mar 31 2021₹6mn/a

₹37m

Dec 31 2020n/an/a

₹17m

Sep 30 2020n/an/a

₹4m

Jun 30 2020n/an/a

-₹3m

Mar 31 2020₹6mn/a

₹8m

Compensation vs Market: Insufficient data to establish whether Mukund's total compensation is reasonable compared to companies of similar size in the Indian market.

Compensation vs Earnings: Mukund's compensation has been consistent with company performance over the past year.

CEO

Mukund Mehta (71 yo)

32.7yrs

Tenure

₹6,000,000

Compensation

Mr. Mukund Prataprai Mehta, B.Com, LL B., serves as the Chairman and Managing Director at Kilitch Drugs (India) Limited and has been its Executive Director since May 12, 1992. Mr. Mehta served as the Compl...

Leadership Team

NamePositionTenureCompensationOwnership
Mukund Mehta
Executive Chairman & MDno data₹6.00m7.09%
₹ 370.0m
Mira Mehta
Managing Directorless than a year₹2.40m5.23%
₹ 272.8m
Bhavin Mehta
Whole-time Directorno data₹8.40m15.69%
₹ 818.5m
Sunil Jain
Chief Financial Officer3.8yrs₹1.50mno data
Tajouddin Ansari
VP-Marketing & Operationno datano datano data
Rajesh Khatri
General Manager - Administrationno datano datano data
Pushpa Nyoupane
Company Secretary & Compliance Officer2.7yrsno datano data

2.7yrs

Average Tenure

48yo

Average Age

Experienced Management: 524500's management team is considered experienced (2.7 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Mukund Mehta
Executive Chairman & MD32.7yrs₹6.00m7.09%
₹ 370.0m
Mira Mehta
Managing Director10.2yrs₹2.40m5.23%
₹ 272.8m
Bhavin Mehta
Whole-time Director7.3yrs₹8.40m15.69%
₹ 818.5m
Hemang Engineer
Independent & Non Executive Director16.6yrs₹25.00kno data
Vasudev Murti
Non-Executive Independent Director6.8yrs₹30.00kno data
Venkita Rajan
Independent Non-Executive Director6.6yrs₹5.00kno data
Dipen Jain
Non- Executive Independent Directorless than a yearno datano data

7.3yrs

Average Tenure

65yo

Average Age

Experienced Board: 524500's board of directors are considered experienced (7.3 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/02 05:43
End of Day Share Price 2025/01/02 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Kilitch Drugs (India) Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution